Diego A. Díaz García (@diegoadiazg) 's Twitter Profile
Diego A. Díaz García

@diegoadiazg

Medical Oncologist | Fellow in Thoracic Oncology @incanMX / CánCare • Hospital Ángeles del Carmen / Opinions my own

ID: 229303152

linkhttp://cancare.com.mx calendar_today22-12-2010 02:09:20

1,1K Tweet

1,1K Followers

1,1K Following

Diego A. Díaz García (@diegoadiazg) 's Twitter Profile Photo

🫁 Evolving roles of MET as a therapeutic target in NSCLC and beyond. 🔹 MET alterations are reshaping the therapeutic landscape in NSCLC. 🔹 MET TKIs, antibodies, and ADCs (like telisotuzumab vedotin, FDA-approved May 2025) are expanding treatment options. 📖 NatureRevClinOncol

🫁 Evolving roles of MET as a therapeutic target in NSCLC and beyond. 

🔹 MET alterations are reshaping the therapeutic landscape in NSCLC.
🔹 MET TKIs, antibodies, and ADCs (like telisotuzumab vedotin, FDA-approved May 2025) are expanding treatment options.

📖 <a href="/NatRevClinOncol/">NatureRevClinOncol</a>